News

Press Releases

May 7, 2019
Verve Therapeutics Founded to Protect Against Heart Disease Launches with $58.5 Million in Series A Funding Led by GV

Media Contact
Lisa Raffensperger
Ten Bridge Communications
(617) 903-8783

Presentations and Publications

See all

In the News

May 10, 2019
One-off injection may drastically reduce heart attack risk
The Guardian
May 7, 2019
With a superstar cardiologist as its CEO, new CRISPR company targets heart disease
STAT
May 7, 2019
One of the world’s top experts in coronary heart disease is spearheading a new gene editing upstart out to transform the field
Endpoints News
 

Stay Connected

Find us on LinkedIn and Twitter